Catherine Green is Professor of Clinical Biomanufacturing at the University of Oxford, where she heads the Nuffield Department of Medicine’s Clinical Biomanufacturing Facility and is a Fellow at Exeter College, Oxford.
Currently, Professor Green specialises in creating vaccines for clinical trials. She and her team at the have manufactured several novel vaccines for first-in-human trials, targeting diseases such as malaria, Ebola virus, tuberculosis, influenza, Zika virus, Middle East respiratory syndrome and rabies, amongst others.
In 2021, Green was awarded an OBE for her services to science and public health following her significant contribution as manufacturing lead in the development of the OxfordAstraZeneca COVID-19 vaccine.

